Anti-NR10 antibody which is any one of: (1) an antibody comprising a heavy chain variable region comprising CDR1 of SEQ ID NO: 9, CDR2 of SEQ ID NO: 197 and CDR3 of SEQ ID NO: 184 (H30 , H44) and a variable chain chain region comprising CDR1 of SEQ ID NO: 202, CDR2 of SEQ ID NO: 170 and CDR3 of SEQ ID NO: 193 (L17)； (2) an antibody comprising a heavy chain variable region comprising CDR1 of SEQ ID NO: 196, CDR2 of SEQ ID NO: 197 and CDR3 of SEQ ID NO: 184 (H28, H42) and a variable light chain region comprising CDR1 of SEQ ID NO: 202, CDR2 of SEQ ID NO: 170 and CDR3 of SEQ ID NO: 193 (L17)； (3) an antibody comprising a heavy chain variable region comprising CDR1 of SEQ ID NO: 176, CDR2 of SEQ ID NO: 197, CDR3 of SEQ ID NO: 184 (H34, H46) and a variable light chain region comprising CDR1 of SEQ ID NO: 202, CDR2 of SEQ ID NO: 170 and CDR3 of SEQ ID NO: 193 (L17)； (4) an antibody comprising a heavy chain variable region comprising CDR1 of SEQ ID NO: 9, CDR2 of SEQ ID NO: 198 and CDR3 of SEQ ID NO: 184 (H57, H78) and a variable light chain region comprising CDR1 of SEQ ID NO: 202, CDR2 of SEQ ID NO: 170 and CDR3 of SEQ ID NO: 193 (L17)； (5) an antibody comprising a heavy chain variable region comprising CDR1 of SEQ ID NO: 176, CDR2 of SEQ ID NO: 198 and CDR3 of SEQ ID NO: 184 (H71, H92) and a variable light chain region comprising CDR1 of SEQ ID NO: 202, CDR2 of SEQ ID NO: 170 and CDR3 of SEQ ID NO: 193 (L17)； and (6) an antibody comprising a heavy chain variable region comprising CDR1 of SEQ ID NO: 9, CDR2 of SEQ ID NO: 199 and CDR3 of SEQ ID NO: 184 (H97, H98) and a variable chain region lightweight comprising CDR1 of SEQ ID NO: 203, CDR2 of SEQ ID NO: 170 and CDR3 of SEQ ID NO: 193 (L50).Anticuerpo anti-NR10 que es uno cualquiera de: (1) un anticuerpo que comprende una región variable de cadena pesada que comprende CDR1 de SEQ ID NO: 9, CDR2 de SEQ ID NO: 197 y CDR3 de SEQ ID NO: 184 (H30, H44) y una región variable de cadenaligera que comprende CDR1 de SEQ ID NO: 202
